APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 95 filers reported holding APPLIED GENETIC TECHNOL CORP in Q3 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $44,000 | -4.3% | 6,000 | -48.6% | 0.00% | – |
| Q3 2017 | $46,000 | -85.9% | 11,677 | -81.7% | 0.00% | -100.0% |
| Q2 2017 | $326,000 | -56.1% | 63,877 | -40.7% | 0.00% | -60.0% |
| Q1 2017 | $743,000 | -23.3% | 107,700 | +4.0% | 0.01% | -28.6% |
| Q4 2016 | $969,000 | +2591.7% | 103,600 | +2700.0% | 0.01% | – |
| Q3 2016 | $36,000 | -23.4% | 3,700 | +12.1% | 0.00% | – |
| Q2 2016 | $47,000 | -33.8% | 3,300 | -35.3% | 0.00% | -100.0% |
| Q1 2016 | $71,000 | +163.0% | 5,100 | +292.3% | 0.00% | – |
| Q4 2015 | $27,000 | +200.0% | 1,300 | +85.7% | 0.00% | – |
| Q3 2015 | $9,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,455,904 | $7,075,000 | 2.04% |
| DAFNA Capital Management LLC | 1,095,139 | $5,322,000 | 1.73% |
| Portolan Capital Management | 1,301,075 | $6,323,000 | 0.72% |
| Sofinnova Investments, Inc. | 825,071 | $4,010,000 | 0.30% |
| Ikarian Capital, LLC | 545,884 | $2,654,000 | 0.19% |
| 683 Capital Management, LLC | 364,299 | $1,770,000 | 0.13% |
| Gyon Technologies Capital Management, LP | 18,653 | $91,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 336,900 | $1,637,000 | 0.07% |
| HighVista Strategies LLC | 15,200 | $74,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 176,411 | $857,000 | 0.04% |